David Cognetti MD FACS
Head & Neck Oncologic Surgery
Chair, Department of Otolaryngology - Head and Neck Surgery
Join to view full profile
925 Chestnut StPhiladelphia, PA 19107
Phone+1 215-955-6760
Fax+1 215-923-4532
Dr. Cognetti is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David M. Cognetti, MD is the Herbert Kean, MD Professor and Chair of the Department of Otolaryngology – Head and Neck Surgery at the Sidney Kimmel Medical College/Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, PA.
Education & Training
UPMC Medical EducationFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2007 - 2008
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Otolaryngology - Head and Neck Surgery, 2002 - 2007- Sidney Kimmel Medical College at Thomas Jefferson UniversityInternship, Transitional Year, 2002 - 2003
University of Pittsburgh School of MedicineClass of 2002
Certifications & Licensure
NJ State Medical License 2021 - 2027
PA State Medical License 2002 - 2026
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
Clinical Trials
- The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy Start of enrollment: 2011 Aug 24
- Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Publications & Presentations
PubMed
- 3 citationsNeoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm...Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson, Kathryn Nunes, Pablo Llerena
Clinical Cancer Research. 2026-11-02 - Head and Neck Cancer Care in Patients with Obesity: Practical Considerations from Diagnosis to Adjuvant Therapy.D Alexander Cronkite, Emma De Ravin, David M Cognetti
Otolaryngologic Clinics of North America. 2026-09-29 - Bilateral Ophthalmoplegia After Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma.Leonard E Estephan, Peter Jacoby, David M Cognetti, Steven A Manobianco
The Laryngoscope. 2026-08-06
Journal Articles
- Association of Positive Initial Margins with Survival Among Patients with Squamous Cell Carcinoma Treated with Total LaryngectomyCorey Savard, David Cognetti, Michael C Topf, William Keane, Joseph Curry, Patrick Tassone, Adam Luginbuhl, JAMA
Authored Content
- AAO-HNSF 2022: Forward Together and Back TogetherSeptember 2022
Press Mentions
Sleep Apnea, Hearing Loss, Cancer, Airway Disorders, Facial Nerve Conditions, and More Presented at AAO-HNSF 2025 Annual MeetingOctober 13th, 2025- A Remarkable Year in Foundation EducationSeptember 2nd, 2024
Doctors Say There’s an Alarming Increase in Oral Cancer Due to HPVMay 3rd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
